Kietpeerakool Chumnan, Cheewakriangkrai Chalong, Suprasert Prapaporn, Srisomboon Jatupol
Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
J Obstet Gynaecol Res. 2009 Jun;35(3):507-13. doi: 10.1111/j.1447-0756.2008.00992.x.
To evaluate the feasibility of the 'see and treat' approach in the management of women with 'atypical squamous cell, cannot exclude high-grade squamous intraepithelial lesion' (ASC-H) on cervical cytology.
All women with ASC-H, who had undergone the see and treat approach between October 2004 and January 2008 at Chiang Mai University Hospital, were reviewed. Similar cohorts, who had undergone conventional management during the same period, were recruited as a comparative group.
One-hundred and eight women with ASC-H smears were available for review. Fifty-eight (53.7%) women had undergone see and treat approach and the remaining 50 had undergone conventional management. There was no significant difference in final histological diagnosis between the conventional and the see and treat group (P = 0.32). The time interval from colposcopy to final histological diagnosis in the see and treat group was shorter than that in the conventional group, particularly for women with high-grade squamous intraepithelial lesion (HSIL) histology or higher (P = 0.004). Of the 58 women in the see and treat group, 14 had no lesions (cervical intraepithelial neoplasia or cancer) on loop electrosurgical excision procedure histology, for an overtreatment rate of 24.1% on the basis of cytology alone. When stratified by colposcopic findings, the overtreatment rate was 61.1% in women who had low-grade lesions or lesser on colposcopy, which was significantly higher than that in women who had high-grade lesions (7.5%, P < 0.001). Multivariate analysis revealed that women with low-grade lesions or lesser on colposcopy had 18.25 times (95% confidence interval (CI) = 3.82-87.23, P < 0.001) greater risk of overtreatment after adjusting for age, parity, menopausal status, contraceptive methods and adequacy of colposcopy.
Selective use of the see and treat approach in women with ASC-H smears who have high-grade lesions on colposcopy is feasible with an acceptable overtreatment rate.
评估“即见即治”方法用于管理宫颈细胞学检查结果为“非典型鳞状细胞,不能排除高级别鳞状上皮内病变”(ASC-H)的女性的可行性。
对2004年10月至2008年1月期间在清迈大学医院接受“即见即治”方法的所有ASC-H女性进行回顾性研究。选取同期接受传统管理的类似队列作为对照组。
108例ASC-H涂片的女性可供评估。58例(53.7%)女性接受了“即见即治”方法,其余50例接受了传统管理。传统管理组和“即见即治”组的最终组织学诊断无显著差异(P = 0.32)。“即见即治”组从阴道镜检查到最终组织学诊断的时间间隔短于传统管理组,尤其是对于组织学诊断为高级别鳞状上皮内病变(HSIL)或更高级别病变的女性(P = 0.004)。在“即见即治”组的58例女性中,14例在环形电切术组织学检查中无病变(宫颈上皮内瘤变或癌症),仅基于细胞学检查的过度治疗率为24.1%。按阴道镜检查结果分层时,阴道镜检查发现低级别病变或更低级别病变的女性过度治疗率为61.1%,显著高于高级别病变女性(7.5%,P < 0.001)。多因素分析显示,在调整年龄、产次、绝经状态、避孕方法和阴道镜检查充分性后,阴道镜检查发现低级别病变或更低级别病变的女性过度治疗风险高18.25倍(95%置信区间(CI)= 3.82 - 87.23,P < 0.001)。
对于阴道镜检查发现高级别病变的ASC-H涂片女性,选择性使用“即见即治”方法是可行的,过度治疗率可接受。